Skip to content
Riskpilot
← Back to search
Sign in
Get full access
PULMOPHARMA ApS
APS
Active
Advertising protection
CVR 36428023
Bøgebjerg 2, 8400
Ebeltoft
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 11 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
PULMOPHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
DM
Dan Mønster Nielsen
Management
Management
2014
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
TB
Torben Ballegaard Sørensen
Chairman
Chairman
2021
PF
Peter Frithjof Bang
Board of Directors
Board of Directors
2021
PB
Per Bendix Jeppesen
Board of Directors
Board of Directors
2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
PETER BANG HOLDING ApS
Company
25–33.32%
25–33.32%
2023
LARS NYENSTAD ApS
Company
20–24.99%
20–24.99%
2025
LouMar ApS
Company
20–24.99%
20–24.99%
2025
BENDIX-HOLDING ApS
Company
20–24.99%
20–24.99%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on PULMOPHARMA ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
